A Non-Profit Works to Advance a DMD Gene Therapy

RARECast - Un podcast de RARECast - Les jeudis

Essayez Nextory gratuitement pendant un mois.

Un univers rempli de livres audio, cliquez ici pour essayer

Catégories:

Frederic Revah, CEO of Genethon, discusses Duchenne muscular dystrophy, the organization’s efforts to complete clinical development of its gene therapy for the condition, and how it might commercialize the treatment.

Visit the podcast's native language site